<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Borowczyk M</submitter><funding>Polish National Center for Science</funding><pagination>638</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9913827</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(3)</volume><pubmed_abstract>Pre- and postsurgical differentiation between follicular thyroid adenoma (FTA) and follicular thyroid cancer (FTC) represents a significant diagnostic challenge. Furthermore, it remains unclear whether they share a common or distinct background and what the mechanisms underlying follicular thyroid lesions malignancy are. The study aimed to compare FTA and FTC by the comprehensive microarray and to identify recurrent regions of loss of heterozygosity (LOH). We analyzed formalin-fixed paraffin-embedded (FFPE) samples acquired from 32 Caucasian patients diagnosed with FTA (16) and FTC (16). We used the OncoScan™ microarray assay (Affymetrix, USA), using highly multiplexed molecular inversion probes for single nucleotide polymorphism (SNP). The total number of LOH was higher in FTC compared wi</pubmed_abstract><journal>Cancers</journal><pubmed_title>Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study.</pubmed_title><pmcid>PMC9913827</pmcid><funding_grant_id>2015/19/N/NZ5/02257</funding_grant_id><funding_grant_id>PRELUDIUM Grant of the number 2015/19/N/NZ5/02257</funding_grant_id><pubmed_authors>Filipowicz D</pubmed_authors><pubmed_authors>Verburg FA</pubmed_authors><pubmed_authors>Wrotkowska E</pubmed_authors><pubmed_authors>Oszywa M</pubmed_authors><pubmed_authors>Janicka-Jedynska M</pubmed_authors><pubmed_authors>Ruchala M</pubmed_authors><pubmed_authors>Debicki S</pubmed_authors><pubmed_authors>Ziemnicka K</pubmed_authors><pubmed_authors>Szczepanek-Parulska E</pubmed_authors><pubmed_authors>Budny B</pubmed_authors><pubmed_authors>Borowczyk M</pubmed_authors><pubmed_authors>Dobosz P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study.</name><description>Pre- and postsurgical differentiation between follicular thyroid adenoma (FTA) and follicular thyroid cancer (FTC) represents a significant diagnostic challenge. Furthermore, it remains unclear whether they share a common or distinct background and what the mechanisms underlying follicular thyroid lesions malignancy are. The study aimed to compare FTA and FTC by the comprehensive microarray and to identify recurrent regions of loss of heterozygosity (LOH). We analyzed formalin-fixed paraffin-embedded (FFPE) samples acquired from 32 Caucasian patients diagnosed with FTA (16) and FTC (16). We used the OncoScan™ microarray assay (Affymetrix, USA), using highly multiplexed molecular inversion probes for single nucleotide polymorphism (SNP). The total number of LOH was higher in FTC compared wi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-08-16T03:06:19.71Z</modification><creation>2025-04-06T07:57:48.386Z</creation></dates><accession>S-EPMC9913827</accession><cross_references><pubmed>36765597</pubmed><doi>10.3390/cancers15030638</doi></cross_references></HashMap>